Loading clinical trials...
Loading clinical trials...
The Auxiliary Effect of Artificial Intelligence in the Detection of Precancerous Lesions in Proximal Colon Cancer: A Multicenter Randomized Controlled Study
The investigators conducted a multicenter randomized controlled trial to explore the adjuvant effect of artificial intelligence in the detection of precancerous lesions in the proximal colon.This is a prospective, multicenter, single-blind, parallel randomized controlled trial.During the colonoscopy retraction process, the investigators aimed to compare the detection rates of proximal colon adenomas with and without the assistance of an AI(Artificial Intelligence) diagnostic device.
Age
All ages
Sex
ALL
Healthy Volunteers
No
the Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
Start Date
February 26, 2026
Primary Completion Date
August 1, 2028
Completion Date
August 1, 2028
Last Updated
January 14, 2026
1,200
ESTIMATED participants
AI group
PROCEDURE
Serial group
PROCEDURE
Standard colonoscopy group
PROCEDURE
Lead Sponsor
Limian Er
NCT07462481
NCT07344402
NCT07231796
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions